IMI Stakeholder Forum 2017 - Open innovation
Start Date 18/10/2017 End Date 19/10/2017The IMI Stakeholder Forum 2018 took place on Wednesday 18 and Thursday 19 October 2017 at the Hotel Crowne Plaza Le Palace, Brussels.
18 October
Open innovation | Agenda
Keynote: Iain Gillespie | Pro-Vice-Chancellor Research and Enterprise at the University of Leicester
Presentation
Video recording
Discussion, moderated by Pierre Meulien:
- Iain Gillespie
- Nathalie Moll | Director General, European Federation of Pharmaceutical Industries and Associations (EFPIA)
- Kurt Vandenberghe | Director Policy Development and Coordination, DG Research and Innovation, European Commission
Chantal Mathieu | Professor of Medicine and Program Director of Biomedical Sciences at the Katholieke Universiteit Leuven | IMI INNODIA project
Presentation
Video recording
Emilio Merlo Pich | Head, Quantitative Medicine & Partnering, CNS Therapeutic Area, Vice-President, Takeda
Presentation
Video recording
Aled Edwards | Director and CEO of the Structural Genomics Consortium (SGC), Professor at the University of Toronto and Visiting Professor at the University of Oxford | IMI ULTRA-DD project
Presentation
Video recording
Topics to be launched under IMI2 - Call 13
Hugh Laverty, Head of Science Operations, Innovative Medicines Initiative (IMI)
Presentation
Video recording
Think Big | IMI pipeline 2018-2020
Salah-Dine Chibout, Global Head Discovery & Investigative Safety, Novartis
Presentation
Video recording
19 October
Patient Forum | Agenda
In IMI’s public-private open innovation model, patients are the ultimate recipients of IMI’s R&D efforts, and an invaluable partner in research. This event, co-developed by IMI and the European Patients’ Forum (EPF) set out discussions on how to achieve real and meaningful patient engagement, how to measure and demonstrate its value, and how to secure willingness to collaborate. The goal of the event was to further the discussion on what are the most meaningful models of patient collaboration in order for patients’ voices to be heard.
This track was chaired by Tamsin Rose | Director, Progress Works.
Keynote: Nicola Bedlington | Secretary General, European Patient Forum
Video recording
Patient involvement | Return on engagement
Dominique Hamerlijnck | EUPATI fellow, patient advocate at the Dutch Lung Foundation
Presentation
Video recording
Discussion:
- Jacqueline Broerse | Research Director of the Faculty of Sciences; Full professor of innovation and communication; Director of the Athena Institute (FALW), Vrije Universisiteit Amsterdam
- Magda Chlebus | Director Science Policy, EFPIA
- Julian Isla | Founder and Chairman of the Dravet Syndrome Foundation | President of the Dravet Syndrome European Federation
- Lucia Monaco | Chief Scientific Officer, Telethon Foundation
- Sue Pavitt | Professor of Translational & Applied Health Research at the University of Leeds
- Eileen Penman | Member of the EPAD Research Participant Panel
Patient outcome perspective on big data & digital health: what role for patients?
The IMI Big Data for Better Outcome Programme | Patricia van Dijck | Director Healthcare System Solutions, Novartis Oncology Europe; IMI Harmony project
Presentation
Discussion:
- Juan Garcia Burgos | Head of Public Engagement, Stakeholders and Communications, European Medicines Agency (EMA)
- Ilaria Passarani | Head of Food and Health, BEUC
- Patricia van Dijck | Novartis
- Spyros Zorbas | Member of the patient advisory group of the IMI RADAR-CNS project
Redefining patient engagement: innovative models of collaboration
Discussion:
- Olivier Arnaud | Senior Director, European Research, JDRF International
- Annette Bakker | President and Chief Scientific Officer, Children's Tumour Foundation
- James Cusack | Director of Research, Autistica
- Matthias Gottwald | Head R&D Policy and Networking, Bayer
- Lee Wen Hwa | Director, Oxford Martin Programme on Affordable Medicines at the University of Oxford; Director, Disease Foundations Network, Strategic Alliances at the Structural Genomics Consortium; IMI ULTRA-DD project
19 October
Microbiome forum | Agenda
The microbiome has come under the spotlight in recent years for its potential to be a turning point in medical research. The challenges it entails, however, require breakthrough collaboration between a diverse range of leading health stakeholders, from both the private and public sectors. This event brought together the pharmaceutical, food / feed and diagnostics industries for an open and dynamic discussion with medtechs, regulators, researchers and other players on the needs for and benefits of collaborative research in the microbiome field.
Keynote: Human microbiome in health & disease
Dusko Ehlrich | International Human Microbiome Consortium
Presentation | coming soon
Video recording | coming soon
Regulatory challenges in the drug-food continuum
Yolanda Sanz | Professor of Research Microbial Ecology, Nutrition & Health Research Unit, Institute of Agrochemistry and Food Technology (IATA), National Research Council (CSIC), Spain
Presentation
Video recording
Nino Mihokovic | Quality Specialist, European Medicines Agency
Presentation
Video recording
Q&A chaired by Maria Beatriz Da Silva Lima, Chair of the IMI Scientific Committee, Professor of Pharmacology and Pharmatoxicology, University of Lisbon
Video recording
Stakeholder discussion | The potential of collaborative research: accelerating breakthroughs and reducing fragmentation in microbiome research
- Frank Møller Aarestrup | Global Microbial Indentifier
- Antoine Coutant | Managing Director, Savencia Ingredients and Nutritional Solutions
- Wulf Fischer-Knuppertz | CEO & Chairman, Biocrates Life Sciences
- Marco Greco | President of the European Patients’ Forum (EPF), Past Chairman of the European Federation of Crohn’s and Ulcerative Colitis Associations (EFCCA)
- Dirk Hadrich | Scientific Officer, DG Research & Innovation, European Commission
- Kristof Van Emelen | CSO – Product Development, ProDigest
- Vijay Yajnik | Medical Director, Clinical Science, GI TAU, Takeda
Themes under consideration for potential microbiome topics under an IMI Call for proposals
Large longitudinal studies with open access to metadata
Stefan J. Scherer | VP Global Head Correlative Science, Novartis Pharmaceuticals Corporation
Presentation
Video recording
Bio-informatics solutions for strain level identification and analysis of hypothetical genes
Alain Pluquet | Corporate VP, Chief Data Officer, bioMerieux
Presentation
Video recording
Bio-banks of identifiable species with metadata, reference methods and standards
Alain Pluquet | Corporate VP, Chief Data Officer, bioMerieux
Presentation
Video recording
Translational studies addressing microbiome causality in human health and disease
James R. Brown, presented by Graham Somers, IMI Portfolio Director, GSK
Presentation
Video recording
Conclusions
Summary & conclusions from the Patient Forum
Catherine Brett, External Relations Manager, Innovative Medicines Initiative (IMI)
Presentation
Video recording
Summary & conclusions from the Microbiome Forum
Elisabetta Vaudano, Principal Scientific Manager, Innovative Medicines Initiative (IMI)
Presentation
Video recording
Anders Olauson | Honorary President, European Patient Forum
Video recording
Stay up to date
To stay up to date with our events, sign up to our newsletter, join our LinkedIn group, or follow us on Twitter at @IMI_JU. If you have any questions or suggestions for next year's Stakeholder Forum, do not hesitate to contact us.